Technology evaluation: VEGF Trap (cancer), Regeneron/sanofi-aventis.
Lau, Sin C Rosa, Daniela D
Lau, Sin C
Rosa, Daniela D
Citations
Altmetric:
Abstract
sanofi-aventis (formerly Aventis) and Regeneron are developing systemic VEGF Trap, a soluble decoy receptor comprising portions of VEGF receptors 1 and 2, for the potential intravenous/subcutaneous treatment of cancer.
Authors
Lau, Sin C
Rosa, Daniela D
Jayson, Gordon C
Rosa, Daniela D
Jayson, Gordon C
Description
Date
2005-10
Publisher
Collections
Keywords
Cancer
Type
Article
Citation
Technology evaluation: VEGF Trap (cancer), Regeneron/sanofi-aventis. 2005, 7 (5):493-501 Curr. Opin. Mol. Ther.